{"gene":"SIK3","run_date":"2026-04-28T20:42:07","timeline":{"discoveries":[{"year":2005,"finding":"14-3-3 isoforms bind directly to the phosphorylated T-loop threonine of SIK3 (after LKB1-mediated phosphorylation), enhancing catalytic activity and requiring 14-3-3 binding for cytoplasmic localization of SIK3; mutation of the T-loop Thr prevents 14-3-3 interaction in vitro.","method":"Tandem affinity purification, co-immunoprecipitation, in vitro binding assays with T-loop mutants, subcellular localization imaging","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1-2 — reciprocal pulldown, mutagenesis, localization with functional consequence, replicated across cell lines and knockout conditions","pmids":["16306228"],"is_preprint":false},{"year":2013,"finding":"LKB1 acts through SIK3 (and SIK2) to phosphorylate class IIa HDACs (HDAC4, -5, -7, -9) at conserved motifs, stimulating 14-3-3 binding and nuclear export; SIK3 can induce nuclear export of HDACs independent of kinase activity and 14-3-3 binding, distinguishing it mechanistically from SIK2.","method":"Kinase assays, co-immunoprecipitation, subcellular localization by fluorescence microscopy, dominant-negative and kinase-dead mutant analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro kinase assay plus epistasis and localization with functional consequence in single study","pmids":["23393134"],"is_preprint":false},{"year":2012,"finding":"SIK3 is required for chondrocyte hypertrophy during skeletal development: SIK3 phosphorylates and anchors HDAC4 in the cytoplasm, thereby releasing MEF2C from nuclear HDAC4-mediated repression to facilitate hypertrophic gene expression.","method":"SIK3 knockout mice, chondrocyte-specific overexpression/rescue, HDAC4 subcellular localization by immunofluorescence, histology","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype, pathway placement via epistasis, rescue experiment, replicated by localization data","pmids":["22318228"],"is_preprint":false},{"year":2012,"finding":"SIK3 regulates glucose and lipid homeostasis in mice; SIK3-deficient mice display lipodystrophy, hypoglycemia, and hyper-insulin sensitivity associated with reduced fatty acid synthesis gene expression, and cholestasis linked to dysregulated retinoid/nuclear receptor signaling.","method":"SIK3 knockout mouse phenotyping, gene expression analysis, pharmacological rescue with 9-cis-retinoic acid","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with defined metabolic phenotype, but pathway placement is inferred rather than direct biochemical reconstitution","pmids":["22662228"],"is_preprint":false},{"year":2015,"finding":"In Drosophila, the LKB1-SIK3-HDAC4 axis controls lipid metabolism: fasting signals (via adipokinetic hormone/glucagon-like pathway) reduce LKB1-mediated SIK3 T196 phosphorylation, decreasing SIK3 activity, which allows HDAC4 nuclear localization and brummer (ATGL homolog) gene expression to promote lipolysis; insulin independently regulates SIK3 activity in feeding conditions.","method":"Genetic epistasis in Drosophila fat body, biochemical SIK3 phosphorylation assays, HDAC4 nuclear localization imaging, mutant rescue","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 1-2 — genetic epistasis plus biochemical phosphorylation measurement plus localization, multiple orthogonal methods in single study","pmids":["25996931"],"is_preprint":false},{"year":2016,"finding":"Pterosin B inhibits the SIK3 pathway and prevents chondrocyte hypertrophy; chondrocyte-specific SIK3 conditional knockout mice are resistant to osteoarthritis with thickened articular cartilage and a larger chondrocyte population.","method":"Conditional knockout mice, intraarticular drug injection, histology, kinase inhibition assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with defined cellular phenotype plus pharmacological inhibitor with matching phenotype","pmids":["27009967"],"is_preprint":false},{"year":2016,"finding":"SIK2 and SIK3 (and SIK1) are required for macrophage polarization; knock-in mice with catalytically inactive SIK2/SIK3 reveal that inhibition of these isoforms during macrophage differentiation drives a stable anti-inflammatory phenotype with high IL-10 and low TNFα even after kinase reactivation.","method":"Catalytically inactive knock-in mice for each SIK isoform, primary macrophage cytokine profiling, pharmacological SIK inhibitors","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 — catalytically inactive KI mice (genetic loss-of-function) with defined cytokine phenotype, replicated with pharmacological inhibitors","pmids":["27920213"],"is_preprint":false},{"year":2018,"finding":"A single PKA phosphorylation site on SIK3 (S551) mediates 14-3-3 binding and regulates daily NREMS amounts and sleep need: S551A and S551D mutations each reproduce the hypersomnia phenotype of Sleepy mutant mice, and deletion or mutation at S551 reduces PKA recognition and abolishes 14-3-3 binding.","method":"Point-mutant knock-in mice (S551A, S551D), EEG/EMG sleep analysis, 14-3-3 binding assays, PKA recognition assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — mutagenesis at defined site with in vivo phenotype and biochemical binding assay, orthogonal methods in single study","pmids":["30254177"],"is_preprint":false},{"year":2018,"finding":"PTH/PTHrP signaling acts through SIK3 to regulate mTOR activity in chondrocytes; a loss-of-function SIK3 mutation causes accumulation of DEPTOR (a negative regulator of mTOR), reducing mTORC1 and mTORC2 activity, establishing SIK3 as a positive regulator of mTOR via DEPTOR degradation during skeletogenesis.","method":"Patient-derived chondrocytes with SIK3 mutation, JMC disease model, mTOR/DEPTOR western blotting, PTHrP receptor activation assays","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 2 — human disease mutation plus disease model with defined molecular mechanism (DEPTOR accumulation), two independent disease contexts","pmids":["30232230"],"is_preprint":false},{"year":2018,"finding":"In osteoblasts, PTH(1-34) inhibits SIK2 and SIK3 via PKA, leading to nuclear localization of CRTC2/CRTC3 and regulation of Rankl expression; SIK2/SIK3 knockdown and PP1/PP2A inhibition place these kinases and phosphatases in the pathway controlling CRTC3 nuclear export and Rankl transcription.","method":"siRNA knockdown of SIK2, SIK3, CRTC3 in primary calvarial osteoblasts, CRTC localization imaging, cAMP/PKA assays, in vivo Rankl measurement","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA KD with defined molecular readout and localization, but single lab","pmids":["30377251"],"is_preprint":false},{"year":2019,"finding":"SIK1 and SIK3 mediate key tumor-suppressive effects of LKB1 in NSCLC; genetic loss of Sik3 (combined with Sik1) increases tumor growth in Kras-driven lung cancer mouse models; the SIK substrate CRTC2 is required for AP1/IL6 upregulation and proliferation benefits seen upon SIK1/3 loss.","method":"CRISPR knockout in NSCLC cell lines, conditional mouse models, gene expression analysis, CRTC2 genetic requirement test","journal":"Cancer discovery","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function in multiple cell lines and mouse models with defined molecular pathway (CRTC2-AP1/IL6), orthogonal methods","pmids":["31350328"],"is_preprint":false},{"year":2017,"finding":"In Drosophila, SIK3 in morning clock neurons (M cells) regulates male sex drive rhythm non-cell-autonomously by modulating HDAC4 nucleocytoplasmic shuttling; loss of Sik3 in M cells disrupts PERIOD cycling in DN1 neurons and constitutive nuclear HDAC4 shortens the MSDR period.","method":"Tissue-specific Sik3 knockdown in Drosophila, circadian behavioral assays, HDAC4 localization imaging in clock neurons","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — genetic manipulation with defined cellular and molecular phenotype in single study","pmids":["28743754"],"is_preprint":false},{"year":2019,"finding":"SIK3 in Drosophila glia controls extracellular K+ and water homeostasis by promoting cytosolic localization of HDAC4, thereby relieving inhibition of Mef2-dependent transcription of K+ and water transport molecules; loss of SIK3 causes fluid accumulation in nerves, neuronal hyperexcitability, and seizures.","method":"Drosophila glial-specific SIK3 loss-of-function, HDAC4 localization, electrophysiology, seizure behavioral assay, transcriptional analysis","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — clean loss-of-function with defined cellular phenotype and pathway placement, multiple orthogonal readouts","pmids":["31645458"],"is_preprint":false},{"year":2022,"finding":"MST3 (mammalian sterile 20-like kinase 3) is a new upstream kinase that can phosphorylate and activate SIK3 independently of LKB1; recombinant MST3 directly phosphorylates SIK3 in vitro, and MST3 from human embryonic kidney cells phosphorylates SIK3 in vivo.","method":"Biochemical purification of phosphorylation activity, in vitro kinase assay with purified recombinant MST3 and SIK3, in vivo phosphorylation in HEK cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro kinase reconstitution plus in vivo validation","pmids":["35413286"],"is_preprint":false},{"year":2019,"finding":"SIK3 promotes chondrocyte maturation by increasing acetyl-CoA levels through suppression of PDK4 (pyruvate dehydrogenase kinase 4), thereby maintaining active PDH and pyruvate-to-acetyl-CoA flux; SIK3 knockout chondrocytes show elevated phospho-PDH and PDK4 with decreased acetyl-CoA.","method":"Metabolome analysis of Sik3 KO chondrocytes, immunohistochemistry for phospho-PDH and PDK4, organ culture with PDH inhibitor","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — KO metabolomics plus pharmacological validation in organ culture, single lab","pmids":["31280862"],"is_preprint":false},{"year":2021,"finding":"Neuron-specific expression of the gain-of-function SIK3(SLP) mutant allele in mature neurons (after late infancy) is sufficient to increase NREMS amounts and NREMS delta power, establishing that SIK3 signaling in neurons (not peripheral tissues) underlies sleep homeostasis.","method":"Inducible Cre-mediated conditional expression of SIK3(SLP) in neurons, EEG/EMG sleep analysis","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — cell-type-specific conditional gain-of-function with defined sleep phenotype, single lab","pmids":["33558433"],"is_preprint":false},{"year":2023,"finding":"SIK3-HDAC4 signaling in the suprachiasmatic nucleus (SCN) regulates circadian period length and timing of arousal: SIK3 deficiency in GABAergic/NMS neurons delays arousal onset and lengthens circadian period; HDAC4 S245A (resistant to SIK3 phosphorylation) delays arousal; heterozygous HDAC4 deficiency shortens period.","method":"Cell-type-specific SIK3 conditional knockout mice, gain-of-function SIK3 mutant induction in GABAergic neurons, HDAC4 S245A knock-in mice, EEG/EMG and circadian behavioral assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic models (KO, gain-of-function, phospho-dead knock-in) with defined behavioral and molecular phenotypes","pmids":["36877841"],"is_preprint":false},{"year":2023,"finding":"SIK3 forms a complex with HDAC4 in hippocampal neurons, directly phosphorylates HDAC4, and regulates its nucleocytoplasmic shuttling to control expression of synaptic plasticity-related genes via MEF2C and histone deacetylase recruitment; SIK3 deletion accelerates cognitive deterioration in an AD mouse model.","method":"Co-immunoprecipitation, western blotting, ChIP-qPCR, immunofluorescence for HDAC4 localization, conditional hippocampal SIK3 deletion, electrophysiology","journal":"Neuropsychopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP plus localization plus conditional KO with functional readout, single lab","pmids":["38057370"],"is_preprint":false},{"year":2025,"finding":"The human NSS SIK3-N783Y mutation results in diminished kinase activity in vitro and, in a mouse knock-in model, decreases sleep time while increasing EEG delta power; at the phosphoproteomic level, this mutation induces changes predominantly at synaptic sites and alters PKA and MAPK signaling networks.","method":"In vitro kinase activity assay, knock-in mouse model, EEG/EMG analysis, phosphoproteomics","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro kinase assay plus in vivo knock-in phenotype plus phosphoproteomics, multiple orthogonal methods","pmids":["40324078"],"is_preprint":false},{"year":2024,"finding":"SIK3 conditional knockout in osteoclasts leads to increased bone mass and an osteopetrosis phenotype; SIK3 deletion and pterosin B treatment inhibit osteoclast differentiation and reduce resorption activity, with alterations in TCA cycle and oxidative phosphorylation metabolism.","method":"Osteoclast-specific SIK3 conditional knockout mice, in vitro osteoclast differentiation assay, pterosin B pharmacology, gene expression analysis, metabolic pathway analysis","journal":"Journal of bone and mineral research","confidence":"Medium","confidence_rationale":"Tier 2 — conditional KO with defined bone phenotype plus pharmacological corroboration, single lab","pmids":["39030684"],"is_preprint":false},{"year":2023,"finding":"In Drosophila, Wnk kinase phosphorylates Fray (a transcriptional target of the SIK3 K+ buffering program) in glia, and this converges with SIK3-dependent transcriptional regulation to control Na+/K+/Cl- co-transporter activity, K+ buffering, and seizure susceptibility.","method":"Drosophila genetics (SIK3 pathway upregulation, Wnk manipulations), electrophysiology, seizure behavioral assays, cell-type-specific expression of constitutively active Fray","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis plus cell-type-specific rescue, single lab","pmids":["36626385"],"is_preprint":false},{"year":2024,"finding":"SIK3 granulosa cell-specific knockout results in infertility, gonadotropin insensitivity, reduced estradiol, fewer antral follicles, increased apoptosis, and decreased proliferation in follicles, demonstrating SIK3 is required for normal granulosa cell function and follicle development.","method":"Granulosa cell-specific SIK3 conditional knockout (Cyp19a1pII-Cre x SIK3-floxed), hormone assays, superovulation, histology, apoptosis/proliferation staining","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — conditional KO with defined reproductive phenotype, single lab","pmids":["39158086"],"is_preprint":false}],"current_model":"SIK3 is a serine/threonine kinase activated by LKB1 (and also MST3) via T-loop phosphorylation, which then promotes 14-3-3 binding to class IIa HDACs (particularly HDAC4), causing their cytoplasmic sequestration and thereby de-repressing MEF2-dependent transcriptional programs that regulate chondrocyte hypertrophy, glial K+/water homeostasis, lipid metabolism, macrophage polarization, sleep homeostasis, and circadian timing; PKA phosphorylation of SIK3 at S551 recruits 14-3-3 to SIK3 itself, modulating its activity and cytoplasmic localization, and this PKA-SIK3-HDAC4 axis is the central intracellular mechanism controlling sleep need and duration in mammals."},"narrative":{"teleology":[{"year":2005,"claim":"Establishing that 14-3-3 proteins directly bind the LKB1-phosphorylated T-loop of SIK3 resolved how upstream activation is coupled to SIK3 catalytic competence and cytoplasmic retention.","evidence":"Tandem affinity purification, co-IP, T-loop mutant binding assays, and subcellular localization imaging in mammalian cells","pmids":["16306228"],"confidence":"High","gaps":["Structural basis of 14-3-3–SIK3 interaction not determined","Whether T-loop phosphorylation is sufficient for full activation in vivo was not tested"]},{"year":2012,"claim":"Demonstrating that SIK3 phosphorylates HDAC4 to sequester it in the cytoplasm and release MEF2C-dependent transcription in chondrocytes established the core SIK3–HDAC4–MEF2 signaling axis and its first physiological role in skeletal development.","evidence":"SIK3 knockout mice with chondrocyte hypertrophy defects, HDAC4 localization rescue, and epistasis analysis","pmids":["22318228","23393134"],"confidence":"High","gaps":["Direct phosphorylation sites on HDAC4 mapped only generically to conserved motifs","Relative contributions of SIK3 versus SIK2 to HDAC phosphorylation in vivo not fully separated"]},{"year":2012,"claim":"SIK3 knockout mouse metabolic phenotyping revealed roles in glucose and lipid homeostasis beyond the skeleton, broadening SIK3's physiological scope to include adipose and hepatic metabolism.","evidence":"SIK3 knockout mice showing lipodystrophy, hypoglycemia, cholestasis; pharmacological rescue with 9-cis-retinoic acid","pmids":["22662228"],"confidence":"Medium","gaps":["Direct substrates mediating metabolic effects not identified","Pathway placement inferred rather than biochemically reconstituted"]},{"year":2015,"claim":"Drosophila genetic epistasis placed SIK3 downstream of fasting/glucagon-like signals and insulin, and upstream of HDAC4 nuclear entry and lipolytic gene expression, providing a complete hormonal pathway from organismal energy state to lipid catabolism.","evidence":"Drosophila fat body genetics, SIK3 phosphorylation assays, HDAC4 localization, mutant rescue","pmids":["25996931"],"confidence":"High","gaps":["Whether insulin and glucagon pathways converge on the same SIK3 phosphosite not resolved","Mammalian conservation of this specific lipolytic circuit not tested"]},{"year":2016,"claim":"Pharmacological inhibition (pterosin B) and conditional knockout of SIK3 in chondrocytes prevented osteoarthritis, establishing SIK3 as a druggable target in cartilage disease, while catalytically inactive SIK knock-in mice revealed that SIK3 kinase activity is required for pro-inflammatory macrophage polarization.","evidence":"Chondrocyte-specific SIK3 cKO mice plus intraarticular pterosin B; catalytically inactive SIK2/SIK3 knock-in mice with macrophage cytokine profiling","pmids":["27009967","27920213"],"confidence":"High","gaps":["Molecular targets of SIK3 in macrophages not identified","Selectivity of pterosin B across SIK family not fully characterized"]},{"year":2017,"claim":"Showing that SIK3 in Drosophila clock neurons regulates HDAC4 shuttling and non-cell-autonomously controls PERIOD cycling in downstream neurons first linked SIK3-HDAC4 to circadian timing.","evidence":"Tissue-specific Sik3 knockdown in Drosophila morning clock neurons, circadian behavioral assays, HDAC4 localization","pmids":["28743754"],"confidence":"Medium","gaps":["Mechanism of non-cell-autonomous signal transmission from M cells to DN1 neurons unknown","Mammalian circadian role not yet demonstrated at this time point"]},{"year":2018,"claim":"Identification of PKA phosphorylation at S551 as the site mediating 14-3-3 binding to SIK3 itself, and demonstration that point mutations at this site reproduce the Sleepy hypersomnia phenotype, established the PKA–SIK3 axis as the molecular switch controlling mammalian NREM sleep need.","evidence":"S551A and S551D knock-in mice with EEG/EMG, 14-3-3 binding assays, PKA recognition assays","pmids":["30254177"],"confidence":"High","gaps":["How S551 phosphorylation status is regulated by wakefulness-associated neuromodulators not determined","Direct downstream phospho-targets of SIK3 in sleep-regulating neurons not identified"]},{"year":2018,"claim":"Linking a human SIK3 loss-of-function mutation to DEPTOR accumulation and reduced mTOR activity in chondrocytes revealed a second effector arm (mTOR via DEPTOR) distinct from the HDAC4 pathway, explaining additional aspects of skeletal disease.","evidence":"Patient-derived chondrocytes with SIK3 mutation, JMC disease model, DEPTOR/mTOR western blotting","pmids":["30232230"],"confidence":"High","gaps":["Whether SIK3 directly phosphorylates DEPTOR or acts indirectly not resolved","Generalizability of DEPTOR mechanism beyond chondrocytes unknown"]},{"year":2018,"claim":"Placing SIK3 downstream of PTH/PKA and upstream of CRTC2/CRTC3 nuclear export in osteoblasts expanded the substrate repertoire to include CRTCs and linked the kinase to RANKL-driven bone remodeling.","evidence":"siRNA knockdown of SIK2/SIK3/CRTC3 in primary osteoblasts, CRTC localization imaging, cAMP/PKA assays","pmids":["30377251"],"confidence":"Medium","gaps":["Relative contribution of SIK3 versus SIK2 to CRTC phosphorylation not dissected","In vivo bone phenotype of SIK3-only loss not shown in this study"]},{"year":2019,"claim":"Genetic studies in NSCLC models showed SIK1/SIK3 double loss recapitulates LKB1 tumor-suppressive loss via CRTC2–AP1/IL6, positioning SIK3 as a key LKB1 effector in cancer suppression.","evidence":"CRISPR knockout in NSCLC lines, Kras-driven mouse lung cancer models, CRTC2 requirement testing","pmids":["31350328"],"confidence":"High","gaps":["Whether SIK3 alone is sufficient for tumor suppression without SIK1 not clear","Patient-derived genomic evidence for SIK3 loss in NSCLC not presented"]},{"year":2019,"claim":"Demonstrating that SIK3 in Drosophila glia drives MEF2-dependent expression of K+ and water transport genes via HDAC4 cytoplasmic retention established a glial-autonomous role for SIK3 in ion homeostasis and seizure prevention.","evidence":"Glial-specific SIK3 loss-of-function in Drosophila, HDAC4 localization, electrophysiology, transcriptional analysis","pmids":["31645458"],"confidence":"High","gaps":["Mammalian glial conservation not demonstrated","Whether SIK3 regulation of K+ homeostasis contributes to its sleep phenotype not tested"]},{"year":2021,"claim":"Neuron-specific inducible expression of the gain-of-function SIK3(SLP) allele proved that neuronal SIK3 activity is sufficient for the hypersomnia phenotype, excluding peripheral contributions.","evidence":"Inducible Cre-mediated SIK3(SLP) expression in mature neurons, EEG/EMG sleep analysis","pmids":["33558433"],"confidence":"Medium","gaps":["Which neuronal populations are responsible not resolved","Whether the SLP truncation creates a neomorphic function not excluded"]},{"year":2022,"claim":"Identification of MST3 as an alternative upstream kinase that directly phosphorylates and activates SIK3 independently of LKB1 expanded the activation logic of SIK3 beyond the canonical AMPK-related kinase pathway.","evidence":"In vitro kinase reconstitution with purified MST3 and SIK3, in vivo phosphorylation in HEK cells","pmids":["35413286"],"confidence":"High","gaps":["Physiological context in which MST3 rather than LKB1 activates SIK3 not determined","Whether MST3 and LKB1 phosphorylate identical or overlapping T-loop sites not mapped"]},{"year":2023,"claim":"Demonstrating that SIK3 deficiency in SCN GABAergic/NMS neurons delays arousal and lengthens circadian period, while HDAC4 S245A knock-in phenocopies the delay, established the SIK3–HDAC4 axis as a circadian period regulator in the master clock.","evidence":"Cell-type-specific SIK3 cKO and gain-of-function mice, HDAC4 S245A knock-in, EEG/EMG and circadian behavioral assays","pmids":["36877841"],"confidence":"High","gaps":["Transcriptional targets downstream of HDAC4 in SCN neurons not identified","How SIK3-HDAC4 integrates with core clock gene oscillations unknown"]},{"year":2023,"claim":"Co-IP and ChIP-qPCR in hippocampal neurons placed SIK3–HDAC4–MEF2C at synaptic plasticity gene promoters, and conditional SIK3 deletion accelerated cognitive decline in an Alzheimer's model, extending the axis to neurodegeneration.","evidence":"Co-IP, ChIP-qPCR, immunofluorescence, conditional hippocampal SIK3 deletion, electrophysiology in AD model mice","pmids":["38057370"],"confidence":"Medium","gaps":["Causal relationship between SIK3 loss and amyloid/tau pathology not established","Single lab finding awaits independent replication"]},{"year":2025,"claim":"The human Natural Short Sleep SIK3-N783Y mutation was shown to reduce kinase activity and decrease sleep time while altering synaptic phosphoproteomes enriched for PKA/MAPK substrates, providing the first human genetic variant linking SIK3 to sleep duration and revealing its broad signaling footprint at synapses.","evidence":"In vitro kinase assay, knock-in mouse EEG/EMG, phosphoproteomics","pmids":["40324078"],"confidence":"High","gaps":["How N783Y allele affects HDAC4 phosphorylation specifically not tested","Whether PKA/MAPK phosphoproteomic changes are direct or indirect SIK3 effects unknown"]},{"year":null,"claim":"The direct phospho-substrates of SIK3 in sleep-regulating neurons, the structural basis for SIK3 regulation by S551 phosphorylation and 14-3-3 binding, and whether the HDAC4 and CRTC effector arms operate in parallel or are cell-type-segregated remain major open questions.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal structure or cryo-EM model of SIK3 available","Neuron-type-specific substrates of SIK3 not catalogued","Integration of HDAC4 and CRTC branches across tissues not systematically tested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,2,7,8,13,17,18]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,4,6,10,16]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,7]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,17]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,5,8,14]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[3,4,14,19]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[6]},{"term_id":"R-HSA-9909396","term_label":"Circadian clock","supporting_discovery_ids":[11,16]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[12,15,17,18]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,7,9,13]}],"complexes":[],"partners":["HDAC4","LKB1","MST3","CRTC2","CRTC3","MEF2C","DEPTOR","YWHAZ"],"other_free_text":[]},"mechanistic_narrative":"SIK3 is an LKB1- and MST3-activated serine/threonine kinase that functions as a central signaling hub linking upstream cAMP/PKA and energy-sensing inputs to chromatin regulation, sleep homeostasis, skeletal development, metabolism, and immune polarization. Its core mechanism involves phosphorylation of class IIa HDACs (particularly HDAC4), promoting 14-3-3 binding and cytoplasmic sequestration of HDACs, which de-represses MEF2-dependent transcription programs controlling chondrocyte hypertrophy, glial ion/water homeostasis, circadian timing, and synaptic plasticity gene expression [PMID:23393134, PMID:22318228, PMID:31645458, PMID:36877841, PMID:38057370]. PKA phosphorylation of SIK3 at S551 recruits 14-3-3 to SIK3 itself and is required for normal NREM sleep amounts and sleep need; both loss- and gain-of-function mutations at this site cause hypersomnia, establishing the PKA–SIK3–HDAC4 axis as the principal intracellular pathway controlling mammalian sleep duration [PMID:30254177, PMID:33558433, PMID:40324078]. Beyond the HDAC4 branch, SIK3 regulates CRTC2/CRTC3 nuclear export to control RANKL expression in osteoblasts and mediates LKB1 tumor-suppressive signaling through CRTC2–AP1/IL6 in NSCLC, and promotes mTOR activity by driving DEPTOR degradation in chondrocytes [PMID:30377251, PMID:31350328, PMID:30232230]."},"prefetch_data":{"uniprot":{"accession":"Q9Y2K2","full_name":"Serine/threonine-protein kinase SIK3","aliases":["Salt-inducible kinase 3","SIK-3","Serine/threonine-protein kinase QSK"],"length_aa":1321,"mass_kda":144.9,"function":"Positive regulator of mTOR signaling that functions by triggering the degradation of DEPTOR, an mTOR inhibitor. Involved in the dynamic regulation of mTOR signaling in chondrocyte differentiation during skeletogenesis (PubMed:30232230). Negatively regulates cAMP signaling pathway possibly by acting on CRTC2/TORC2 and CRTC3/TORC3 (Probable). Prevents HDAC4 translocation to the nucleus (By similarity)","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q9Y2K2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SIK3","classification":"Not Classified","n_dependent_lines":17,"n_total_lines":1208,"dependency_fraction":0.014072847682119206},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"ARPC2","stoichiometry":0.2},{"gene":"TNPO1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/SIK3","total_profiled":1310},"omim":[{"mim_id":"620112","title":"APOA1 ANTISENSE RNA, NONCODING; APOA1AS","url":"https://www.omim.org/entry/620112"},{"mim_id":"618162","title":"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK","url":"https://www.omim.org/entry/618162"},{"mim_id":"614776","title":"SIK FAMILY KINASE 3; SIK3","url":"https://www.omim.org/entry/614776"},{"mim_id":"612975","title":"SHORT SLEEP, FAMILIAL NATURAL, 1; FNSS1","url":"https://www.omim.org/entry/612975"},{"mim_id":"605314","title":"HISTONE DEACETYLASE 4; HDAC4","url":"https://www.omim.org/entry/605314"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SIK3"},"hgnc":{"alias_symbol":["FLJ12240","L19","KIAA0999","QSK"],"prev_symbol":[]},"alphafold":{"accession":"Q9Y2K2","domains":[{"cath_id":"1.10.510.10","chopping":"148-342","consensus_level":"medium","plddt":92.661,"start":148,"end":342}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y2K2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y2K2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y2K2-F1-predicted_aligned_error_v6.png","plddt_mean":50.66},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SIK3","jax_strain_url":"https://www.jax.org/strain/search?query=SIK3"},"sequence":{"accession":"Q9Y2K2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y2K2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y2K2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y2K2"}},"corpus_meta":[{"pmid":"3542997","id":"PMC_3542997","title":"The primary structure of rat ribosomal protein L19. A determination from the sequence of nucleotides in a cDNA and from the sequence of amino acids in the protein.","date":"1987","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3542997","citation_count":152,"is_preprint":false},{"pmid":"25971540","id":"PMC_25971540","title":"Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study.","date":"2015","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/25971540","citation_count":150,"is_preprint":false},{"pmid":"20797845","id":"PMC_20797845","title":"The tumour-targeting human L19-IL2 immunocytokine: preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma.","date":"2010","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/20797845","citation_count":149,"is_preprint":false},{"pmid":"22028492","id":"PMC_22028492","title":"A dose-escalation and signal-generating study of the immunocytokine L19-IL2 in combination with dacarbazine for the therapy of patients with metastatic melanoma.","date":"2011","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/22028492","citation_count":126,"is_preprint":false},{"pmid":"19005180","id":"PMC_19005180","title":"Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19005180","citation_count":122,"is_preprint":false},{"pmid":"31350328","id":"PMC_31350328","title":"The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC.","date":"2019","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/31350328","citation_count":119,"is_preprint":false},{"pmid":"8095182","id":"PMC_8095182","title":"High-level expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2.","date":"1993","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/8095182","citation_count":102,"is_preprint":false},{"pmid":"6357787","id":"PMC_6357787","title":"The nucleotide sequence of an Escherichia coli operon containing genes for the tRNA(m1G)methyltransferase, the ribosomal proteins S16 and L19 and a 21-K polypeptide.","date":"1983","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/6357787","citation_count":98,"is_preprint":false},{"pmid":"16306228","id":"PMC_16306228","title":"14-3-3 cooperates with LKB1 to regulate the activity and localization of QSK and SIK.","date":"2005","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/16306228","citation_count":94,"is_preprint":false},{"pmid":"25552483","id":"PMC_25552483","title":"Radiotherapy combined with the immunocytokine L19-IL2 provides long-lasting antitumor effects.","date":"2014","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/25552483","citation_count":86,"is_preprint":false},{"pmid":"23393134","id":"PMC_23393134","title":"The tumor suppressor kinase LKB1 activates the downstream kinases SIK2 and SIK3 to stimulate nuclear export of class IIa histone deacetylases.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23393134","citation_count":83,"is_preprint":false},{"pmid":"23160853","id":"PMC_23160853","title":"Phase I/II study of the tumour-targeting human monoclonal antibody-cytokine fusion protein L19-TNF in patients with advanced solid tumours.","date":"2012","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23160853","citation_count":81,"is_preprint":false},{"pmid":"24906352","id":"PMC_24906352","title":"Intralesional treatment of stage III metastatic melanoma patients with L19-IL2 results in sustained clinical and systemic immunologic responses.","date":"2014","source":"Cancer immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/24906352","citation_count":81,"is_preprint":false},{"pmid":"27009967","id":"PMC_27009967","title":"Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27009967","citation_count":76,"is_preprint":false},{"pmid":"16818947","id":"PMC_16818947","title":"Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.","date":"2006","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16818947","citation_count":76,"is_preprint":false},{"pmid":"22318228","id":"PMC_22318228","title":"SIK3 is essential for chondrocyte hypertrophy during skeletal development in mice.","date":"2012","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22318228","citation_count":74,"is_preprint":false},{"pmid":"25996931","id":"PMC_25996931","title":"Feeding and Fasting Signals Converge on the LKB1-SIK3 Pathway to Regulate Lipid Metabolism in Drosophila.","date":"2015","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25996931","citation_count":73,"is_preprint":false},{"pmid":"18676770","id":"PMC_18676770","title":"The targeted immunocytokine L19-IL2 efficiently inhibits the growth of orthotopic pancreatic cancer.","date":"2008","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/18676770","citation_count":70,"is_preprint":false},{"pmid":"863909","id":"PMC_863909","title":"Isolation of eukaryotic ribosomal proteins. Purification and characterization of 60 S ribosomal subunit proteins L3, L6, L7', L8, L10, L15, L17, L18, L19, L23', L25, L27', L28, L29, L31, L32, L34, L35, L36, L36', and L37'.","date":"1977","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/863909","citation_count":68,"is_preprint":false},{"pmid":"22674435","id":"PMC_22674435","title":"Isolated limb perfusion with the tumor-targeting human monoclonal antibody-cytokine fusion protein L19-TNF plus melphalan and mild hyperthermia in patients with locally advanced extremity melanoma.","date":"2012","source":"Journal of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22674435","citation_count":67,"is_preprint":false},{"pmid":"22662228","id":"PMC_22662228","title":"Involvement of SIK3 in glucose and lipid homeostasis in mice.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22662228","citation_count":67,"is_preprint":false},{"pmid":"27920213","id":"PMC_27920213","title":"Inhibition of SIK2 and SIK3 during differentiation enhances the anti-inflammatory phenotype of macrophages.","date":"2016","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/27920213","citation_count":63,"is_preprint":false},{"pmid":"30377251","id":"PMC_30377251","title":"Parathyroid hormone(1-34) and its analogs differentially modulate osteoblastic Rankl expression via PKA/SIK2/SIK3 and PP1/PP2A-CRTC3 signaling.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30377251","citation_count":57,"is_preprint":false},{"pmid":"30254177","id":"PMC_30254177","title":"A single phosphorylation site of SIK3 regulates daily sleep amounts and sleep need in mice.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30254177","citation_count":56,"is_preprint":false},{"pmid":"32682817","id":"PMC_32682817","title":"Berberine and Emodin abrogates breast cancer growth and facilitates apoptosis through inactivation of SIK3-induced mTOR and Akt signaling pathway.","date":"2020","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/32682817","citation_count":52,"is_preprint":false},{"pmid":"17157877","id":"PMC_17157877","title":"Compensatory evolution reveals functional interactions between ribosomal proteins S12, L14 and L19.","date":"2006","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17157877","citation_count":48,"is_preprint":false},{"pmid":"32539805","id":"PMC_32539805","title":"Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial.","date":"2020","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32539805","citation_count":46,"is_preprint":false},{"pmid":"29632732","id":"PMC_29632732","title":"The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses.","date":"2018","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/29632732","citation_count":44,"is_preprint":false},{"pmid":"30232230","id":"PMC_30232230","title":"The PTH/PTHrP-SIK3 pathway affects skeletogenesis through altered mTOR signaling.","date":"2018","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30232230","citation_count":43,"is_preprint":false},{"pmid":"18799229","id":"PMC_18799229","title":"Comparative immunohistochemistry of L19 and F16 in non-small cell lung cancer and mesothelioma: two human antibodies investigated in clinical trials in patients with cancer.","date":"2008","source":"Lung cancer (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/18799229","citation_count":43,"is_preprint":false},{"pmid":"28658303","id":"PMC_28658303","title":"Critical role of SIK3 in mediating high salt and IL-17 synergy leading to breast cancer cell proliferation.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28658303","citation_count":38,"is_preprint":false},{"pmid":"33688020","id":"PMC_33688020","title":"Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19-IL2 cures poorly immunogenic tumors when combined with radiotherapy.","date":"2021","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33688020","citation_count":38,"is_preprint":false},{"pmid":"7789970","id":"PMC_7789970","title":"The L19 ribosomal protein gene (RPL19): gene organization, chromosomal mapping, and novel promoter region.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7789970","citation_count":36,"is_preprint":false},{"pmid":"24950402","id":"PMC_24950402","title":"Ribosomal protein L19 overexpression activates the unfolded protein response and sensitizes MCF7 breast cancer cells to endoplasmic reticulum stress-induced cell death.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24950402","citation_count":35,"is_preprint":false},{"pmid":"368561","id":"PMC_368561","title":"A transducing lambda phage carrying grpE, a bacterial gene necessary for lambda DNA replication, and two ribosomal protein genes, rpsP (S16) and rplS (L19).","date":"1978","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/368561","citation_count":34,"is_preprint":false},{"pmid":"30586544","id":"PMC_30586544","title":"A novel anti-cancer L19-interleukin-12 fusion protein with an optimized peptide linker efficiently localizes in vivo at the site of tumors.","date":"2018","source":"Journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/30586544","citation_count":32,"is_preprint":false},{"pmid":"26138057","id":"PMC_26138057","title":"Combination of radiotherapy with the immunocytokine L19-IL2: Additive effect in a NK cell dependent tumour model.","date":"2015","source":"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/26138057","citation_count":30,"is_preprint":false},{"pmid":"17519905","id":"PMC_17519905","title":"Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models.","date":"2007","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17519905","citation_count":29,"is_preprint":false},{"pmid":"33545220","id":"PMC_33545220","title":"Distinctive role of SIK1 and SIK3 isoforms in aerobic glycolysis and cell growth of breast cancer through the regulation of p53 and mTOR signaling pathways.","date":"2021","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/33545220","citation_count":29,"is_preprint":false},{"pmid":"25060954","id":"PMC_25060954","title":"Salt-inducible kinase 3, SIK3, is a new gene associated with hearing.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25060954","citation_count":27,"is_preprint":false},{"pmid":"28743754","id":"PMC_28743754","title":"SIK3-HDAC4 signaling regulates Drosophila circadian male sex drive rhythm via modulating the DN1 clock neurons.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28743754","citation_count":25,"is_preprint":false},{"pmid":"1702292","id":"PMC_1702292","title":"Nucleotide sequence of mouse L19 ribosomal protein cDNA isolated in screening with tre oncogene probes.","date":"1990","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/1702292","citation_count":24,"is_preprint":false},{"pmid":"28270177","id":"PMC_28270177","title":"Genetic variants in SERPINA4 and SERPINA5, but not BCL2 and SIK3 are associated with acute kidney injury in critically ill patients with septic shock.","date":"2017","source":"Critical care (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28270177","citation_count":23,"is_preprint":false},{"pmid":"26460958","id":"PMC_26460958","title":"Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26460958","citation_count":23,"is_preprint":false},{"pmid":"1598220","id":"PMC_1598220","title":"Human cDNAs encoding elongation factor 1 gamma and the ribosomal protein L19.","date":"1992","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/1598220","citation_count":23,"is_preprint":false},{"pmid":"7251593","id":"PMC_7251593","title":"Characterization of the binding of rat liver ribosomal proteins L6, L8, L19, S9, and S13 to 5.8 S ribosomal ribonucleic acid.","date":"1981","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7251593","citation_count":22,"is_preprint":false},{"pmid":"7400140","id":"PMC_7400140","title":"Characterization of the binding of rat liver ribosomal proteins L6, L7, and L19 to 5 S ribosomal ribonucleic acid.","date":"1980","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7400140","citation_count":22,"is_preprint":false},{"pmid":"29327244","id":"PMC_29327244","title":"Antibody-based delivery of tumor necrosis factor (L19-TNFα) and interleukin-2 (L19-IL2) to tumor-associated blood vessels has potent immunological and anticancer activity in the syngeneic J558L BALB/c myeloma model.","date":"2018","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29327244","citation_count":21,"is_preprint":false},{"pmid":"27757551","id":"PMC_27757551","title":"FkbN and Tcs7 are pathway-specific regulators of the FK506 biosynthetic gene cluster in Streptomyces tsukubaensis L19.","date":"2016","source":"Journal of industrial microbiology & biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/27757551","citation_count":21,"is_preprint":false},{"pmid":"19799608","id":"PMC_19799608","title":"Identification of ribosomal protein L19 as a novel tumor antigen recognized by autologous cytotoxic T lymphocytes in lung adenocarcinoma.","date":"2009","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/19799608","citation_count":20,"is_preprint":false},{"pmid":"31443604","id":"PMC_31443604","title":"L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31443604","citation_count":20,"is_preprint":false},{"pmid":"36877841","id":"PMC_36877841","title":"SIK3-HDAC4 in the suprachiasmatic nucleus regulates the timing of arousal at the dark onset and circadian period in mice.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/36877841","citation_count":19,"is_preprint":false},{"pmid":"33285270","id":"PMC_33285270","title":"Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study.","date":"2020","source":"International journal of radiation oncology, biology, physics","url":"https://pubmed.ncbi.nlm.nih.gov/33285270","citation_count":19,"is_preprint":false},{"pmid":"38552030","id":"PMC_38552030","title":"Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases.","date":"2024","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/38552030","citation_count":18,"is_preprint":false},{"pmid":"32304410","id":"PMC_32304410","title":"The immunocytokine L19-TNF eradicates sarcomas in combination with chemotherapy agents or with immune check-point inhibitors.","date":"2020","source":"Anti-cancer drugs","url":"https://pubmed.ncbi.nlm.nih.gov/32304410","citation_count":16,"is_preprint":false},{"pmid":"6423642","id":"PMC_6423642","title":"The localization of protein L19 on the surface of 50 S subunits of Escherichia coli aided by the use of mutants lacking protein L19.","date":"1984","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/6423642","citation_count":16,"is_preprint":false},{"pmid":"6773542","id":"PMC_6773542","title":"Purification of Drosophila ribosomal proteins. Isolation of proteins S8, S13, S14, S16, S19, S20/L24, S22/L26, S24, S25/S27, S26, S29, L4, L10/L11, L12, L13, L16, L18, L19, L27, 1, 7/8, 9, and 11.","date":"1980","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/6773542","citation_count":16,"is_preprint":false},{"pmid":"26405576","id":"PMC_26405576","title":"Long-lasting antitumor effects provided by radiotherapy combined with the immunocytokine L19-IL2.","date":"2015","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/26405576","citation_count":15,"is_preprint":false},{"pmid":"31165758","id":"PMC_31165758","title":"Association of BUD13-ZNF259-APOA5-APOA1-SIK3 cluster polymorphism in 11q23.3 and structure of APOA5 with increased plasma triglyceride levels in a Korean population.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31165758","citation_count":14,"is_preprint":false},{"pmid":"368562","id":"PMC_368562","title":"Genes encoding ribosomal proteins S16 and L19 form a gene cluster at 56.4 min in Escherichia coli.","date":"1978","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/368562","citation_count":14,"is_preprint":false},{"pmid":"33558433","id":"PMC_33558433","title":"Induction of Mutant Sik3 Allele in Neurons in Late Infancy Increases Sleep Need.","date":"2021","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/33558433","citation_count":13,"is_preprint":false},{"pmid":"31280862","id":"PMC_31280862","title":"Changes in acetyl-CoA mediate Sik3-induced maturation of chondrocytes in endochondral bone formation.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31280862","citation_count":13,"is_preprint":false},{"pmid":"26577409","id":"PMC_26577409","title":"Directed evolution of nitrilase PpL19 from Pseudomonas psychrotolerans L19 and identification of enantiocomplementary mutants toward mandelonitrile.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/26577409","citation_count":13,"is_preprint":false},{"pmid":"31803362","id":"PMC_31803362","title":"Targeted enhancement of the therapeutic window of L19-TNF by transient and selective inhibition of RIPK1-signaling cascade.","date":"2019","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/31803362","citation_count":13,"is_preprint":false},{"pmid":"38057370","id":"PMC_38057370","title":"Targeting SIK3 to modulate hippocampal synaptic plasticity and cognitive function by regulating the transcription of HDAC4 in a mouse model of Alzheimer's disease.","date":"2023","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38057370","citation_count":12,"is_preprint":false},{"pmid":"29435066","id":"PMC_29435066","title":"Potential anticancer effect of prostratin through SIK3 inhibition.","date":"2017","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/29435066","citation_count":12,"is_preprint":false},{"pmid":"31645458","id":"PMC_31645458","title":"SIK3 suppresses neuronal hyperexcitability by regulating the glial capacity to buffer K+ and water.","date":"2019","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31645458","citation_count":11,"is_preprint":false},{"pmid":"339951","id":"PMC_339951","title":"Primary structure of protein L19 from the large subunit of Escherichia coli ribosomes.","date":"1978","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/339951","citation_count":11,"is_preprint":false},{"pmid":"8444837","id":"PMC_8444837","title":"Cross-linked amino acids in the protein pairs L3-L19 and L23-L29 of Bacillus stearothermophilus ribosomes after treatment with diepoxybutane.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8444837","citation_count":9,"is_preprint":false},{"pmid":"7725803","id":"PMC_7725803","title":"Analysis of a 17.4 kb DNA segment of yeast chromosome II encompassing the ribosomal protein L19 as well as proteins with homologies to components of the hnRNP and snRNP complexes and to the human proliferation-associated p120 antigen.","date":"1994","source":"Yeast (Chichester, England)","url":"https://pubmed.ncbi.nlm.nih.gov/7725803","citation_count":9,"is_preprint":false},{"pmid":"21860608","id":"PMC_21860608","title":"Ribosomal Protein L19 and L22 Modulate TLR3 Signaling.","date":"2011","source":"Immune network","url":"https://pubmed.ncbi.nlm.nih.gov/21860608","citation_count":8,"is_preprint":false},{"pmid":"21956757","id":"PMC_21956757","title":"The ribosomal protein L19 mRNA is induced by copper exposure in the swordtail fish, Xiphophorus helleri.","date":"2011","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/21956757","citation_count":8,"is_preprint":false},{"pmid":"25061042","id":"PMC_25061042","title":"Structure and gene cluster of the O antigen of Escherichia coli L-19, a candidate for a new O-serogroup.","date":"2014","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25061042","citation_count":7,"is_preprint":false},{"pmid":"21033215","id":"PMC_21033215","title":"Fecal RNA detection of cytokeratin 19 and ribosomal protein L19 for colorectal cancer.","date":"2010","source":"Hepato-gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/21033215","citation_count":7,"is_preprint":false},{"pmid":"25290356","id":"PMC_25290356","title":"Characterization of the pattern of ribosomal protein L19 production during the lifecycle of Leishmania spp.","date":"2014","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/25290356","citation_count":6,"is_preprint":false},{"pmid":"39869636","id":"PMC_39869636","title":"Staphylococcus aureus blocks host autophagy through circSyk/miR-5106/Sik3 axis to promote progression of bone infection.","date":"2025","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/39869636","citation_count":6,"is_preprint":false},{"pmid":"35413286","id":"PMC_35413286","title":"Biochemical purification uncovers mammalian sterile 3 (MST3) as a new protein kinase for multifunctional protein kinases AMPK and SIK3.","date":"2022","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35413286","citation_count":6,"is_preprint":false},{"pmid":"40324078","id":"PMC_40324078","title":"The SIK3-N783Y mutation is associated with the human natural short sleep trait.","date":"2025","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/40324078","citation_count":5,"is_preprint":false},{"pmid":"39030684","id":"PMC_39030684","title":"Impact of the SIK3 pathway inhibition on osteoclast differentiation via oxidative phosphorylation.","date":"2024","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/39030684","citation_count":5,"is_preprint":false},{"pmid":"36626385","id":"PMC_36626385","title":"SIK3 and Wnk converge on Fray to regulate glial K+ buffering and seizure susceptibility.","date":"2023","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36626385","citation_count":4,"is_preprint":false},{"pmid":"27477481","id":"PMC_27477481","title":"Alterations in ribosomal protein L19 that decrease the fidelity of translation.","date":"2016","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/27477481","citation_count":4,"is_preprint":false},{"pmid":"7785339","id":"PMC_7785339","title":"Nucleotide sequence and characterization of the Saccharomyces cerevisiae RPL19A gene encoding a homolog of the mammalian ribosomal protein L19.","date":"1995","source":"Yeast (Chichester, England)","url":"https://pubmed.ncbi.nlm.nih.gov/7785339","citation_count":4,"is_preprint":false},{"pmid":"34693928","id":"PMC_34693928","title":"Contribution of APOA5, APOC3, CETP, ABCA1 and SIK3 genetic variants to hypertriglyceridemia development in Mexican HIV-patients receiving antiretroviral therapy.","date":"2022","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/34693928","citation_count":3,"is_preprint":false},{"pmid":"37662102","id":"PMC_37662102","title":"A phosphorylation-deficient mutant of Sik3, a homolog of Sleepy, alters circadian sleep regulation by PDF neurons in Drosophila.","date":"2023","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/37662102","citation_count":3,"is_preprint":false},{"pmid":"37356786","id":"PMC_37356786","title":"Face validation and pharmacologic analysis of Sik3Sleepy mutant mouse as a possible model of idiopathic hypersomnia.","date":"2023","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37356786","citation_count":3,"is_preprint":false},{"pmid":"40711360","id":"PMC_40711360","title":"Structure-Activity Relationship Guided Scaffold Hopping Resulted in the Identification of GLPG4970, a Highly Potent Dual SIK2/SIK3 Inhibitor.","date":"2025","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/40711360","citation_count":2,"is_preprint":false},{"pmid":"34839513","id":"PMC_34839513","title":"[Analysis of SIK3 gene variation in a boy with autism spectrum disorder complicated with epilepsy].","date":"2021","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34839513","citation_count":2,"is_preprint":false},{"pmid":"20828971","id":"PMC_20828971","title":"A new bioassay for the immunocytokine L19-IL2 for simultaneous analysis of both functional moieties.","date":"2010","source":"Journal of pharmaceutical and biomedical analysis","url":"https://pubmed.ncbi.nlm.nih.gov/20828971","citation_count":2,"is_preprint":false},{"pmid":"37854071","id":"PMC_37854071","title":"The AMPK-like protein kinases Sik2 and Sik3 interact with Hipk and induce synergistic tumorigenesis in a Drosophila cancer model.","date":"2023","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/37854071","citation_count":2,"is_preprint":false},{"pmid":"2099152","id":"PMC_2099152","title":"The mammalian genome contains a high proportion of processed pseudogenes corresponding to ribosomal protein L19.","date":"1990","source":"Biochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/2099152","citation_count":2,"is_preprint":false},{"pmid":"39158086","id":"PMC_39158086","title":"SIK2 and SIK3 Differentially Regulate Mouse Granulosa Cell Response to Exogenous Gonadotropins In Vivo.","date":"2024","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/39158086","citation_count":1,"is_preprint":false},{"pmid":"39895792","id":"PMC_39895792","title":"EFHD1 Activates SIK3 to Limit Colorectal Cancer Initiation and Progression via the Hippo Pathway.","date":"2025","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/39895792","citation_count":1,"is_preprint":false},{"pmid":"37715891","id":"PMC_37715891","title":"Knockdown of SIK3 in the CA1 Region can Reduce Seizure Susceptibility in Mice by Inhibiting Decreases in GABAAR α1 Expression.","date":"2023","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/37715891","citation_count":1,"is_preprint":false},{"pmid":"40610343","id":"PMC_40610343","title":"Sleeping less with a SIK3 mutation.","date":"2025","source":"Trends in genetics : TIG","url":"https://pubmed.ncbi.nlm.nih.gov/40610343","citation_count":0,"is_preprint":false},{"pmid":"40117972","id":"PMC_40117972","title":"Trypanosoma brucei L19 is essential for ribosomal function.","date":"2025","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/40117972","citation_count":0,"is_preprint":false},{"pmid":"41271199","id":"PMC_41271199","title":"Dexmedetomidine Alleviates Sleep Rhythm Abnormalities in Chronic Sleep-Deprived Mice via Modulation of SIK3/HDAC4/5 Signalling.","date":"2026","source":"Clinical and experimental pharmacology & physiology","url":"https://pubmed.ncbi.nlm.nih.gov/41271199","citation_count":0,"is_preprint":false},{"pmid":"42033356","id":"PMC_42033356","title":"Evaluating Ribosomal Protein L19 mRNA as a Biomarker in Ulcerative Colitis: Implications for Severity Assessment.","date":"2026","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/42033356","citation_count":0,"is_preprint":false},{"pmid":"41948837","id":"PMC_41948837","title":"Molecular mechanisms of T221 phosphorylation in modulating SIK3 kinase function and ATP binding.","date":"2026","source":"Physical chemistry chemical physics : PCCP","url":"https://pubmed.ncbi.nlm.nih.gov/41948837","citation_count":0,"is_preprint":false},{"pmid":"41657312","id":"PMC_41657312","title":"Selective SIK2/SIK3 inhibition reprograms pro- and antiinflammatory pathways in myeloid cells, improving autoimmune disease outcomes.","date":"2026","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/41657312","citation_count":0,"is_preprint":false},{"pmid":"31723008","id":"PMC_31723008","title":"Glial SIK3: A central player in ion and volume homeostasis in Drosophila peripheral nerves.","date":"2019","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31723008","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49431,"output_tokens":5403,"usd":0.114669},"stage2":{"model":"claude-opus-4-6","input_tokens":8931,"output_tokens":4268,"usd":0.227032},"total_usd":0.341701,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"14-3-3 isoforms bind directly to the phosphorylated T-loop threonine of SIK3 (after LKB1-mediated phosphorylation), enhancing catalytic activity and requiring 14-3-3 binding for cytoplasmic localization of SIK3; mutation of the T-loop Thr prevents 14-3-3 interaction in vitro.\",\n      \"method\": \"Tandem affinity purification, co-immunoprecipitation, in vitro binding assays with T-loop mutants, subcellular localization imaging\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reciprocal pulldown, mutagenesis, localization with functional consequence, replicated across cell lines and knockout conditions\",\n      \"pmids\": [\"16306228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"LKB1 acts through SIK3 (and SIK2) to phosphorylate class IIa HDACs (HDAC4, -5, -7, -9) at conserved motifs, stimulating 14-3-3 binding and nuclear export; SIK3 can induce nuclear export of HDACs independent of kinase activity and 14-3-3 binding, distinguishing it mechanistically from SIK2.\",\n      \"method\": \"Kinase assays, co-immunoprecipitation, subcellular localization by fluorescence microscopy, dominant-negative and kinase-dead mutant analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro kinase assay plus epistasis and localization with functional consequence in single study\",\n      \"pmids\": [\"23393134\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SIK3 is required for chondrocyte hypertrophy during skeletal development: SIK3 phosphorylates and anchors HDAC4 in the cytoplasm, thereby releasing MEF2C from nuclear HDAC4-mediated repression to facilitate hypertrophic gene expression.\",\n      \"method\": \"SIK3 knockout mice, chondrocyte-specific overexpression/rescue, HDAC4 subcellular localization by immunofluorescence, histology\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype, pathway placement via epistasis, rescue experiment, replicated by localization data\",\n      \"pmids\": [\"22318228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SIK3 regulates glucose and lipid homeostasis in mice; SIK3-deficient mice display lipodystrophy, hypoglycemia, and hyper-insulin sensitivity associated with reduced fatty acid synthesis gene expression, and cholestasis linked to dysregulated retinoid/nuclear receptor signaling.\",\n      \"method\": \"SIK3 knockout mouse phenotyping, gene expression analysis, pharmacological rescue with 9-cis-retinoic acid\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined metabolic phenotype, but pathway placement is inferred rather than direct biochemical reconstitution\",\n      \"pmids\": [\"22662228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In Drosophila, the LKB1-SIK3-HDAC4 axis controls lipid metabolism: fasting signals (via adipokinetic hormone/glucagon-like pathway) reduce LKB1-mediated SIK3 T196 phosphorylation, decreasing SIK3 activity, which allows HDAC4 nuclear localization and brummer (ATGL homolog) gene expression to promote lipolysis; insulin independently regulates SIK3 activity in feeding conditions.\",\n      \"method\": \"Genetic epistasis in Drosophila fat body, biochemical SIK3 phosphorylation assays, HDAC4 nuclear localization imaging, mutant rescue\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic epistasis plus biochemical phosphorylation measurement plus localization, multiple orthogonal methods in single study\",\n      \"pmids\": [\"25996931\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Pterosin B inhibits the SIK3 pathway and prevents chondrocyte hypertrophy; chondrocyte-specific SIK3 conditional knockout mice are resistant to osteoarthritis with thickened articular cartilage and a larger chondrocyte population.\",\n      \"method\": \"Conditional knockout mice, intraarticular drug injection, histology, kinase inhibition assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with defined cellular phenotype plus pharmacological inhibitor with matching phenotype\",\n      \"pmids\": [\"27009967\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"SIK2 and SIK3 (and SIK1) are required for macrophage polarization; knock-in mice with catalytically inactive SIK2/SIK3 reveal that inhibition of these isoforms during macrophage differentiation drives a stable anti-inflammatory phenotype with high IL-10 and low TNFα even after kinase reactivation.\",\n      \"method\": \"Catalytically inactive knock-in mice for each SIK isoform, primary macrophage cytokine profiling, pharmacological SIK inhibitors\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — catalytically inactive KI mice (genetic loss-of-function) with defined cytokine phenotype, replicated with pharmacological inhibitors\",\n      \"pmids\": [\"27920213\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A single PKA phosphorylation site on SIK3 (S551) mediates 14-3-3 binding and regulates daily NREMS amounts and sleep need: S551A and S551D mutations each reproduce the hypersomnia phenotype of Sleepy mutant mice, and deletion or mutation at S551 reduces PKA recognition and abolishes 14-3-3 binding.\",\n      \"method\": \"Point-mutant knock-in mice (S551A, S551D), EEG/EMG sleep analysis, 14-3-3 binding assays, PKA recognition assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis at defined site with in vivo phenotype and biochemical binding assay, orthogonal methods in single study\",\n      \"pmids\": [\"30254177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PTH/PTHrP signaling acts through SIK3 to regulate mTOR activity in chondrocytes; a loss-of-function SIK3 mutation causes accumulation of DEPTOR (a negative regulator of mTOR), reducing mTORC1 and mTORC2 activity, establishing SIK3 as a positive regulator of mTOR via DEPTOR degradation during skeletogenesis.\",\n      \"method\": \"Patient-derived chondrocytes with SIK3 mutation, JMC disease model, mTOR/DEPTOR western blotting, PTHrP receptor activation assays\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human disease mutation plus disease model with defined molecular mechanism (DEPTOR accumulation), two independent disease contexts\",\n      \"pmids\": [\"30232230\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In osteoblasts, PTH(1-34) inhibits SIK2 and SIK3 via PKA, leading to nuclear localization of CRTC2/CRTC3 and regulation of Rankl expression; SIK2/SIK3 knockdown and PP1/PP2A inhibition place these kinases and phosphatases in the pathway controlling CRTC3 nuclear export and Rankl transcription.\",\n      \"method\": \"siRNA knockdown of SIK2, SIK3, CRTC3 in primary calvarial osteoblasts, CRTC localization imaging, cAMP/PKA assays, in vivo Rankl measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA KD with defined molecular readout and localization, but single lab\",\n      \"pmids\": [\"30377251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SIK1 and SIK3 mediate key tumor-suppressive effects of LKB1 in NSCLC; genetic loss of Sik3 (combined with Sik1) increases tumor growth in Kras-driven lung cancer mouse models; the SIK substrate CRTC2 is required for AP1/IL6 upregulation and proliferation benefits seen upon SIK1/3 loss.\",\n      \"method\": \"CRISPR knockout in NSCLC cell lines, conditional mouse models, gene expression analysis, CRTC2 genetic requirement test\",\n      \"journal\": \"Cancer discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function in multiple cell lines and mouse models with defined molecular pathway (CRTC2-AP1/IL6), orthogonal methods\",\n      \"pmids\": [\"31350328\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In Drosophila, SIK3 in morning clock neurons (M cells) regulates male sex drive rhythm non-cell-autonomously by modulating HDAC4 nucleocytoplasmic shuttling; loss of Sik3 in M cells disrupts PERIOD cycling in DN1 neurons and constitutive nuclear HDAC4 shortens the MSDR period.\",\n      \"method\": \"Tissue-specific Sik3 knockdown in Drosophila, circadian behavioral assays, HDAC4 localization imaging in clock neurons\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic manipulation with defined cellular and molecular phenotype in single study\",\n      \"pmids\": [\"28743754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SIK3 in Drosophila glia controls extracellular K+ and water homeostasis by promoting cytosolic localization of HDAC4, thereby relieving inhibition of Mef2-dependent transcription of K+ and water transport molecules; loss of SIK3 causes fluid accumulation in nerves, neuronal hyperexcitability, and seizures.\",\n      \"method\": \"Drosophila glial-specific SIK3 loss-of-function, HDAC4 localization, electrophysiology, seizure behavioral assay, transcriptional analysis\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean loss-of-function with defined cellular phenotype and pathway placement, multiple orthogonal readouts\",\n      \"pmids\": [\"31645458\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MST3 (mammalian sterile 20-like kinase 3) is a new upstream kinase that can phosphorylate and activate SIK3 independently of LKB1; recombinant MST3 directly phosphorylates SIK3 in vitro, and MST3 from human embryonic kidney cells phosphorylates SIK3 in vivo.\",\n      \"method\": \"Biochemical purification of phosphorylation activity, in vitro kinase assay with purified recombinant MST3 and SIK3, in vivo phosphorylation in HEK cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro kinase reconstitution plus in vivo validation\",\n      \"pmids\": [\"35413286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SIK3 promotes chondrocyte maturation by increasing acetyl-CoA levels through suppression of PDK4 (pyruvate dehydrogenase kinase 4), thereby maintaining active PDH and pyruvate-to-acetyl-CoA flux; SIK3 knockout chondrocytes show elevated phospho-PDH and PDK4 with decreased acetyl-CoA.\",\n      \"method\": \"Metabolome analysis of Sik3 KO chondrocytes, immunohistochemistry for phospho-PDH and PDK4, organ culture with PDH inhibitor\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO metabolomics plus pharmacological validation in organ culture, single lab\",\n      \"pmids\": [\"31280862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Neuron-specific expression of the gain-of-function SIK3(SLP) mutant allele in mature neurons (after late infancy) is sufficient to increase NREMS amounts and NREMS delta power, establishing that SIK3 signaling in neurons (not peripheral tissues) underlies sleep homeostasis.\",\n      \"method\": \"Inducible Cre-mediated conditional expression of SIK3(SLP) in neurons, EEG/EMG sleep analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific conditional gain-of-function with defined sleep phenotype, single lab\",\n      \"pmids\": [\"33558433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SIK3-HDAC4 signaling in the suprachiasmatic nucleus (SCN) regulates circadian period length and timing of arousal: SIK3 deficiency in GABAergic/NMS neurons delays arousal onset and lengthens circadian period; HDAC4 S245A (resistant to SIK3 phosphorylation) delays arousal; heterozygous HDAC4 deficiency shortens period.\",\n      \"method\": \"Cell-type-specific SIK3 conditional knockout mice, gain-of-function SIK3 mutant induction in GABAergic neurons, HDAC4 S245A knock-in mice, EEG/EMG and circadian behavioral assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic models (KO, gain-of-function, phospho-dead knock-in) with defined behavioral and molecular phenotypes\",\n      \"pmids\": [\"36877841\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SIK3 forms a complex with HDAC4 in hippocampal neurons, directly phosphorylates HDAC4, and regulates its nucleocytoplasmic shuttling to control expression of synaptic plasticity-related genes via MEF2C and histone deacetylase recruitment; SIK3 deletion accelerates cognitive deterioration in an AD mouse model.\",\n      \"method\": \"Co-immunoprecipitation, western blotting, ChIP-qPCR, immunofluorescence for HDAC4 localization, conditional hippocampal SIK3 deletion, electrophysiology\",\n      \"journal\": \"Neuropsychopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP plus localization plus conditional KO with functional readout, single lab\",\n      \"pmids\": [\"38057370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The human NSS SIK3-N783Y mutation results in diminished kinase activity in vitro and, in a mouse knock-in model, decreases sleep time while increasing EEG delta power; at the phosphoproteomic level, this mutation induces changes predominantly at synaptic sites and alters PKA and MAPK signaling networks.\",\n      \"method\": \"In vitro kinase activity assay, knock-in mouse model, EEG/EMG analysis, phosphoproteomics\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro kinase assay plus in vivo knock-in phenotype plus phosphoproteomics, multiple orthogonal methods\",\n      \"pmids\": [\"40324078\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SIK3 conditional knockout in osteoclasts leads to increased bone mass and an osteopetrosis phenotype; SIK3 deletion and pterosin B treatment inhibit osteoclast differentiation and reduce resorption activity, with alterations in TCA cycle and oxidative phosphorylation metabolism.\",\n      \"method\": \"Osteoclast-specific SIK3 conditional knockout mice, in vitro osteoclast differentiation assay, pterosin B pharmacology, gene expression analysis, metabolic pathway analysis\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with defined bone phenotype plus pharmacological corroboration, single lab\",\n      \"pmids\": [\"39030684\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In Drosophila, Wnk kinase phosphorylates Fray (a transcriptional target of the SIK3 K+ buffering program) in glia, and this converges with SIK3-dependent transcriptional regulation to control Na+/K+/Cl- co-transporter activity, K+ buffering, and seizure susceptibility.\",\n      \"method\": \"Drosophila genetics (SIK3 pathway upregulation, Wnk manipulations), electrophysiology, seizure behavioral assays, cell-type-specific expression of constitutively active Fray\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis plus cell-type-specific rescue, single lab\",\n      \"pmids\": [\"36626385\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SIK3 granulosa cell-specific knockout results in infertility, gonadotropin insensitivity, reduced estradiol, fewer antral follicles, increased apoptosis, and decreased proliferation in follicles, demonstrating SIK3 is required for normal granulosa cell function and follicle development.\",\n      \"method\": \"Granulosa cell-specific SIK3 conditional knockout (Cyp19a1pII-Cre x SIK3-floxed), hormone assays, superovulation, histology, apoptosis/proliferation staining\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with defined reproductive phenotype, single lab\",\n      \"pmids\": [\"39158086\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SIK3 is a serine/threonine kinase activated by LKB1 (and also MST3) via T-loop phosphorylation, which then promotes 14-3-3 binding to class IIa HDACs (particularly HDAC4), causing their cytoplasmic sequestration and thereby de-repressing MEF2-dependent transcriptional programs that regulate chondrocyte hypertrophy, glial K+/water homeostasis, lipid metabolism, macrophage polarization, sleep homeostasis, and circadian timing; PKA phosphorylation of SIK3 at S551 recruits 14-3-3 to SIK3 itself, modulating its activity and cytoplasmic localization, and this PKA-SIK3-HDAC4 axis is the central intracellular mechanism controlling sleep need and duration in mammals.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SIK3 is an LKB1- and MST3-activated serine/threonine kinase that functions as a central signaling hub linking upstream cAMP/PKA and energy-sensing inputs to chromatin regulation, sleep homeostasis, skeletal development, metabolism, and immune polarization. Its core mechanism involves phosphorylation of class IIa HDACs (particularly HDAC4), promoting 14-3-3 binding and cytoplasmic sequestration of HDACs, which de-represses MEF2-dependent transcription programs controlling chondrocyte hypertrophy, glial ion/water homeostasis, circadian timing, and synaptic plasticity gene expression [PMID:23393134, PMID:22318228, PMID:31645458, PMID:36877841, PMID:38057370]. PKA phosphorylation of SIK3 at S551 recruits 14-3-3 to SIK3 itself and is required for normal NREM sleep amounts and sleep need; both loss- and gain-of-function mutations at this site cause hypersomnia, establishing the PKA–SIK3–HDAC4 axis as the principal intracellular pathway controlling mammalian sleep duration [PMID:30254177, PMID:33558433, PMID:40324078]. Beyond the HDAC4 branch, SIK3 regulates CRTC2/CRTC3 nuclear export to control RANKL expression in osteoblasts and mediates LKB1 tumor-suppressive signaling through CRTC2–AP1/IL6 in NSCLC, and promotes mTOR activity by driving DEPTOR degradation in chondrocytes [PMID:30377251, PMID:31350328, PMID:30232230].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Establishing that 14-3-3 proteins directly bind the LKB1-phosphorylated T-loop of SIK3 resolved how upstream activation is coupled to SIK3 catalytic competence and cytoplasmic retention.\",\n      \"evidence\": \"Tandem affinity purification, co-IP, T-loop mutant binding assays, and subcellular localization imaging in mammalian cells\",\n      \"pmids\": [\"16306228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of 14-3-3–SIK3 interaction not determined\", \"Whether T-loop phosphorylation is sufficient for full activation in vivo was not tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrating that SIK3 phosphorylates HDAC4 to sequester it in the cytoplasm and release MEF2C-dependent transcription in chondrocytes established the core SIK3–HDAC4–MEF2 signaling axis and its first physiological role in skeletal development.\",\n      \"evidence\": \"SIK3 knockout mice with chondrocyte hypertrophy defects, HDAC4 localization rescue, and epistasis analysis\",\n      \"pmids\": [\"22318228\", \"23393134\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct phosphorylation sites on HDAC4 mapped only generically to conserved motifs\", \"Relative contributions of SIK3 versus SIK2 to HDAC phosphorylation in vivo not fully separated\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"SIK3 knockout mouse metabolic phenotyping revealed roles in glucose and lipid homeostasis beyond the skeleton, broadening SIK3's physiological scope to include adipose and hepatic metabolism.\",\n      \"evidence\": \"SIK3 knockout mice showing lipodystrophy, hypoglycemia, cholestasis; pharmacological rescue with 9-cis-retinoic acid\",\n      \"pmids\": [\"22662228\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct substrates mediating metabolic effects not identified\", \"Pathway placement inferred rather than biochemically reconstituted\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Drosophila genetic epistasis placed SIK3 downstream of fasting/glucagon-like signals and insulin, and upstream of HDAC4 nuclear entry and lipolytic gene expression, providing a complete hormonal pathway from organismal energy state to lipid catabolism.\",\n      \"evidence\": \"Drosophila fat body genetics, SIK3 phosphorylation assays, HDAC4 localization, mutant rescue\",\n      \"pmids\": [\"25996931\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether insulin and glucagon pathways converge on the same SIK3 phosphosite not resolved\", \"Mammalian conservation of this specific lipolytic circuit not tested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Pharmacological inhibition (pterosin B) and conditional knockout of SIK3 in chondrocytes prevented osteoarthritis, establishing SIK3 as a druggable target in cartilage disease, while catalytically inactive SIK knock-in mice revealed that SIK3 kinase activity is required for pro-inflammatory macrophage polarization.\",\n      \"evidence\": \"Chondrocyte-specific SIK3 cKO mice plus intraarticular pterosin B; catalytically inactive SIK2/SIK3 knock-in mice with macrophage cytokine profiling\",\n      \"pmids\": [\"27009967\", \"27920213\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular targets of SIK3 in macrophages not identified\", \"Selectivity of pterosin B across SIK family not fully characterized\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showing that SIK3 in Drosophila clock neurons regulates HDAC4 shuttling and non-cell-autonomously controls PERIOD cycling in downstream neurons first linked SIK3-HDAC4 to circadian timing.\",\n      \"evidence\": \"Tissue-specific Sik3 knockdown in Drosophila morning clock neurons, circadian behavioral assays, HDAC4 localization\",\n      \"pmids\": [\"28743754\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of non-cell-autonomous signal transmission from M cells to DN1 neurons unknown\", \"Mammalian circadian role not yet demonstrated at this time point\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identification of PKA phosphorylation at S551 as the site mediating 14-3-3 binding to SIK3 itself, and demonstration that point mutations at this site reproduce the Sleepy hypersomnia phenotype, established the PKA–SIK3 axis as the molecular switch controlling mammalian NREM sleep need.\",\n      \"evidence\": \"S551A and S551D knock-in mice with EEG/EMG, 14-3-3 binding assays, PKA recognition assays\",\n      \"pmids\": [\"30254177\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How S551 phosphorylation status is regulated by wakefulness-associated neuromodulators not determined\", \"Direct downstream phospho-targets of SIK3 in sleep-regulating neurons not identified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Linking a human SIK3 loss-of-function mutation to DEPTOR accumulation and reduced mTOR activity in chondrocytes revealed a second effector arm (mTOR via DEPTOR) distinct from the HDAC4 pathway, explaining additional aspects of skeletal disease.\",\n      \"evidence\": \"Patient-derived chondrocytes with SIK3 mutation, JMC disease model, DEPTOR/mTOR western blotting\",\n      \"pmids\": [\"30232230\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SIK3 directly phosphorylates DEPTOR or acts indirectly not resolved\", \"Generalizability of DEPTOR mechanism beyond chondrocytes unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Placing SIK3 downstream of PTH/PKA and upstream of CRTC2/CRTC3 nuclear export in osteoblasts expanded the substrate repertoire to include CRTCs and linked the kinase to RANKL-driven bone remodeling.\",\n      \"evidence\": \"siRNA knockdown of SIK2/SIK3/CRTC3 in primary osteoblasts, CRTC localization imaging, cAMP/PKA assays\",\n      \"pmids\": [\"30377251\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contribution of SIK3 versus SIK2 to CRTC phosphorylation not dissected\", \"In vivo bone phenotype of SIK3-only loss not shown in this study\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Genetic studies in NSCLC models showed SIK1/SIK3 double loss recapitulates LKB1 tumor-suppressive loss via CRTC2–AP1/IL6, positioning SIK3 as a key LKB1 effector in cancer suppression.\",\n      \"evidence\": \"CRISPR knockout in NSCLC lines, Kras-driven mouse lung cancer models, CRTC2 requirement testing\",\n      \"pmids\": [\"31350328\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SIK3 alone is sufficient for tumor suppression without SIK1 not clear\", \"Patient-derived genomic evidence for SIK3 loss in NSCLC not presented\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrating that SIK3 in Drosophila glia drives MEF2-dependent expression of K+ and water transport genes via HDAC4 cytoplasmic retention established a glial-autonomous role for SIK3 in ion homeostasis and seizure prevention.\",\n      \"evidence\": \"Glial-specific SIK3 loss-of-function in Drosophila, HDAC4 localization, electrophysiology, transcriptional analysis\",\n      \"pmids\": [\"31645458\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mammalian glial conservation not demonstrated\", \"Whether SIK3 regulation of K+ homeostasis contributes to its sleep phenotype not tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Neuron-specific inducible expression of the gain-of-function SIK3(SLP) allele proved that neuronal SIK3 activity is sufficient for the hypersomnia phenotype, excluding peripheral contributions.\",\n      \"evidence\": \"Inducible Cre-mediated SIK3(SLP) expression in mature neurons, EEG/EMG sleep analysis\",\n      \"pmids\": [\"33558433\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Which neuronal populations are responsible not resolved\", \"Whether the SLP truncation creates a neomorphic function not excluded\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identification of MST3 as an alternative upstream kinase that directly phosphorylates and activates SIK3 independently of LKB1 expanded the activation logic of SIK3 beyond the canonical AMPK-related kinase pathway.\",\n      \"evidence\": \"In vitro kinase reconstitution with purified MST3 and SIK3, in vivo phosphorylation in HEK cells\",\n      \"pmids\": [\"35413286\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological context in which MST3 rather than LKB1 activates SIK3 not determined\", \"Whether MST3 and LKB1 phosphorylate identical or overlapping T-loop sites not mapped\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstrating that SIK3 deficiency in SCN GABAergic/NMS neurons delays arousal and lengthens circadian period, while HDAC4 S245A knock-in phenocopies the delay, established the SIK3–HDAC4 axis as a circadian period regulator in the master clock.\",\n      \"evidence\": \"Cell-type-specific SIK3 cKO and gain-of-function mice, HDAC4 S245A knock-in, EEG/EMG and circadian behavioral assays\",\n      \"pmids\": [\"36877841\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional targets downstream of HDAC4 in SCN neurons not identified\", \"How SIK3-HDAC4 integrates with core clock gene oscillations unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Co-IP and ChIP-qPCR in hippocampal neurons placed SIK3–HDAC4–MEF2C at synaptic plasticity gene promoters, and conditional SIK3 deletion accelerated cognitive decline in an Alzheimer's model, extending the axis to neurodegeneration.\",\n      \"evidence\": \"Co-IP, ChIP-qPCR, immunofluorescence, conditional hippocampal SIK3 deletion, electrophysiology in AD model mice\",\n      \"pmids\": [\"38057370\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal relationship between SIK3 loss and amyloid/tau pathology not established\", \"Single lab finding awaits independent replication\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"The human Natural Short Sleep SIK3-N783Y mutation was shown to reduce kinase activity and decrease sleep time while altering synaptic phosphoproteomes enriched for PKA/MAPK substrates, providing the first human genetic variant linking SIK3 to sleep duration and revealing its broad signaling footprint at synapses.\",\n      \"evidence\": \"In vitro kinase assay, knock-in mouse EEG/EMG, phosphoproteomics\",\n      \"pmids\": [\"40324078\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How N783Y allele affects HDAC4 phosphorylation specifically not tested\", \"Whether PKA/MAPK phosphoproteomic changes are direct or indirect SIK3 effects unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The direct phospho-substrates of SIK3 in sleep-regulating neurons, the structural basis for SIK3 regulation by S551 phosphorylation and 14-3-3 binding, and whether the HDAC4 and CRTC effector arms operate in parallel or are cell-type-segregated remain major open questions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal structure or cryo-EM model of SIK3 available\", \"Neuron-type-specific substrates of SIK3 not catalogued\", \"Integration of HDAC4 and CRTC branches across tissues not systematically tested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 2, 7, 8, 13, 17, 18]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 4, 6, 10, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 7]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0162582\", \"supporting_discovery_ids\": [0, 7, 9, 13]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 5, 8, 14]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [3, 4, 14, 19]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"R-HSA-9909396\", \"supporting_discovery_ids\": [11, 16]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [12, 15, 17, 18]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 7, 9, 13]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"HDAC4\",\n      \"LKB1\",\n      \"MST3\",\n      \"CRTC2\",\n      \"CRTC3\",\n      \"MEF2C\",\n      \"DEPTOR\",\n      \"YWHAZ\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}